{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:03:57Z","timestamp":1761217437739,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":4449,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12603-011-0058-9","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T08:16:21Z","timestamp":1302768981000},"page":"725-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Designing phase II B trials in sarcopenia: The best target population"],"prefix":"10.1016","volume":"15","author":[{"given":"M.","family":"Pahor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5Suppl","key":"10.1007\/s12603-011-0058-9_bib1","first-page":"990S","article-title":"Sarcopenia origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"JNutr"},{"issue":"8","key":"10.1007\/s12603-011-0058-9_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12603-009-0200-0","article-title":"Carla Task Force on Sarcopenia propositions for clinical trials","volume":"13","author":"Abellan van Kan","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/s12603-011-0058-9_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1874827900801010014","article-title":"Sarcopenia current clinical and research issues","volume":"1","author":"Cesari","year":"2008","journal-title":"Open Geriatr Med J"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/aje\/kwh058","article-title":"Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women","volume":"159","author":"Janssen","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1532-5415.2002.50217.x","article-title":"Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health aging and body composition study","volume":"50","author":"Visser","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s12603-011-0058-9_bib7","doi-asserted-by":"crossref","unstructured":"Cesari M, Pahor M, Lauretani F, Zamboni V, Bandinelli S, Bernabei R et al. Skeletal Muscle and Mortality Results From the InCHLANTi Study. J Gerontol A Biol Sci Med Sci. 2009","DOI":"10.1093\/gerona\/gln031"},{"issue":"10","key":"10.1007\/s12603-011-0058-9_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1007\/s12603-011-0058-9_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/gerona\/61.1.72","article-title":"Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort","volume":"61","author":"Newman","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"10.1007\/s12603-011-0058-9_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF02982708","article-title":"Target population for clinical trials on sarcopenia","volume":"12","author":"Cesari","year":"2008","journal-title":"J Nutr Health Aging"},{"issue":"8","key":"10.1007\/s12603-011-0058-9_bib11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s12603-009-0205-8","article-title":"Target population for clinical trials","volume":"13","author":"Studenski","year":"2009","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age and Ageing"},{"issue":"8","key":"10.1007\/s12603-011-0058-9_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/gerona\/63.8.829","article-title":"Sarcopenia =\/= dynapenia","volume":"63","author":"Clark","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mlc.2001.113504","article-title":"Sarcopenia","volume":"137","author":"Morley","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1007\/s12603-011-0058-9_bib15","first-page":"693","article-title":"Sarcopenic obesity: definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: a new category of obesity in the elderfy","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1007\/s12603-011-0058-9_bib17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ajcn\/82.2.428","article-title":"Sarcopenia, obesity, and inflammation-results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study","volume":"82","author":"Cesari","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1007\/s12603-011-0058-9_bib18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","article-title":"Sarcopenia alternative definitions and associations with lower extremity function","volume":"51","author":"Newman","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"10.1007\/s12603-011-0058-9_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/gerona\/58.11.M999","article-title":"Role of apoptosis in sarcopenia","volume":"58","author":"Leeuwenburgh","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1007\/s12603-011-0058-9_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.arr.2006.03.002","article-title":"Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle","volume":"5","author":"Dirks","year":"2006","journal-title":"Ageing Res Rev"},{"issue":"12Pt2","key":"10.1007\/s12603-011-0058-9_bib21","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1301\/nr.2007.dec.S208-S212","article-title":"Physical activity, inflammation, and muscle loss","volume":"65","author":"Roubenoff","year":"2007","journal-title":"Nutr Rev"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib22","doi-asserted-by":"crossref","first-page":"el0805","DOI":"10.1371\/journal.pone.0010805","article-title":"Sarcopenia exacerbates obesity-associated insulin-resistance and dysglycemia findings from the National Health and Nutrition Examination Survey HI","volume":"5","author":"Srikanthan","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1007\/s12603-011-0058-9_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2307\/2533377","article-title":"Practical Bayesian guidelines for phase ECB clinical trials","volume":"50","author":"Thall","year":"1994","journal-title":"Biometrics"},{"issue":"7Pt1","key":"10.1007\/s12603-011-0058-9_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/1078-0432.CCR-05-1136","article-title":"Phase II clinical trial design: methods in translational research from the Genitourinary Committee at the Eastern Cooperative Oncology Group","volume":"12","author":"Gray","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1007\/s12603-011-0058-9_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2288-3-6","article-title":"Design of Phase II cancer trials evaluating survival probabilities","volume":"3","author":"Case","year":"2003","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1007\/s12603-011-0058-9_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12603-011-0058-9_bib27","doi-asserted-by":"crossref","unstructured":"Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, Westendorp RG et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev. 2010","DOI":"10.1016\/j.arr.2010.05.005"},{"issue":"1","key":"10.1007\/s12603-011-0058-9_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5273(02)00237-1","article-title":"Cachexia in rheumatoid arthritis","volume":"85","author":"Walsmith","year":"2002","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1007\/s12603-011-0058-9_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/art.23719","article-title":"Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies","volume":"59","author":"Giles","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1007\/s12603-011-0058-9_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1749-6632.2000.tb06515.x","article-title":"Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis","volume":"904","author":"Roubenoff","year":"2000","journal-title":"Ann NY Acad Sci"},{"issue":"10","key":"10.1007\/s12603-011-0058-9_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1532-5415.2005.53501.x","article-title":"Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study","volume":"53","author":"Cesari","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1532-5415.2007.01087.x","article-title":"Knee extension strength cutpoints for maintaining mobility","volume":"55","author":"Manini","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib33","doi-asserted-by":"crossref","first-page":"M221","DOI":"10.1093\/gerona\/55.4.M221","article-title":"Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery","volume":"55","author":"Guralnik","year":"2000","journal-title":"J Gerontol ABiol SciMed Sci"},{"issue":"9","key":"10.1007\/s12603-011-0058-9_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1532-5415.2007.01087.x","article-title":"Knee extension strength cutpoints for maintaining mobility","volume":"55","author":"Manini","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib36","doi-asserted-by":"crossref","first-page":"M283","DOI":"10.1093\/gerona\/57.5.M283","article-title":"A conceptual framework of frailty: a review","volume":"57","author":"Bortz","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"10.1007\/s12603-011-0058-9_bib37","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1007\/s12603-011-0058-9_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1532-5415.2000.tb04719.x","article-title":"Epidemiology of sarcopenia","volume":"48","author":"Melton","year":"2000","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib39","first-page":"664","article-title":"Ethnic comparisons of sarcopenia and obesity in diabetes","volume":"15","author":"Castaneda","year":"2005","journal-title":"Ethn Dis"},{"issue":"5","key":"10.1007\/s12603-011-0058-9_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ajhb.1099","article-title":"Muscularity in adult humans: proportion of adipose tissue-free body mass as skeletal muscle","volume":"13","author":"Wang","year":"2001","journal-title":"Am J Hum Biol"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib41","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","article-title":"Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index","volume":"72","author":"Gallagher","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1007\/s12603-011-0058-9_bib42","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1152\/jappl.2001.90.6.2157","article-title":"Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study","volume":"90","author":"Goodpaster","year":"2001","journal-title":"J AppI Physiol"},{"issue":"1","key":"10.1007\/s12603-011-0058-9_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00926829","article-title":"Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle","volume":"125","author":"Garcia-Martinez","year":"1993","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1007\/s12603-011-0058-9_bib44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj2580493","article-title":"Effect of recombinant human tumour necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats","volume":"258","author":"Charters","year":"1989","journal-title":"Biochem J"},{"issue":"11","key":"10.1007\/s12603-011-0058-9_bib45","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/gerona\/glp097","article-title":"Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength","volume":"64","author":"Schaap","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib46","first-page":"295","article-title":"Catabolism of aging: is it an inflammatory process?","volume":"6","author":"Roubenoff","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"10.1007\/s12603-011-0058-9_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.blre.2005.12.002","article-title":"Anemia in the elderly: current understanding and emerging concepts","volume":"20","author":"Eisenstaedt","year":"2006","journal-title":"Blood Rev"},{"key":"10.1007\/s12603-011-0058-9_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/bse0440085","article-title":"Improving muscle mass: response of muscle metabolism to exercise, nutrition and anabolic agents","volume":"44","author":"Tipton","year":"2008","journal-title":"Essays Biochem"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib49","first-page":"271","article-title":"Testosterone action on skeletal muscle","volume":"7","author":"Herbst","year":"2004","journal-title":"Curr Opin Clian Nutr Metab Care"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/JOE-09-0431","article-title":"The GHIGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis","volume":"205","author":"Perrini","year":"2010","journal-title":"J Endocrinol"},{"issue":"3\u20134","key":"10.1007\/s12603-011-0058-9_bib51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/ars.2006.8.609","article-title":"Oxidative damage and platelet activation as new predictors of mobility disability and mortality in elders","volume":"8","author":"Cesari","year":"2006","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1007\/s12603-011-0058-9_bib52","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00394.2006","article-title":"Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus","volume":"293","author":"Azuma","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1007\/s12603-011-0058-9_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1007\/s12603-011-0058-9_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"Thesyndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int J Cardiol"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-011-0058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12603-011-0058-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723006140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723006140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12603-011-0058-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:46:42Z","timestamp":1761137202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723006140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1279770723006140"],"URL":"https:\/\/doi.org\/10.1007\/s12603-011-0058-9","relation":{},"ISSN":["1279-7707"],"issn-type":[{"type":"print","value":"1279-7707"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing phase II B trials in sarcopenia: The best target population","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12603-011-0058-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}